Purpose: To review the current state for diagnosis and management of autoimmune
retinopathy. Methods: A review of the literature was performed, encompassing autoimmune …

Purpose To provide a detailed review of current clinical guidelines for the diagnosis, work-
up and treatment of autoimmune retinopathy and to preview briefly possible future therapies …

Autoimmune retinopathy (AIR) refers to a group of rare autoimmune retinal degenerative
diseases presumably caused by cross-reactivity of serum autoantibodies against retinal …

Purpose To provide a comprehensive review of rituximab use for the treatment of non-
infectious uveitis and scleritis. Methods Review of literature through December 2020 …

Background: Dozens of paraneoplastic syndromes affect the visual system ranging from
conjunctival pemphigoid to encephalopathy of the occipital cortex. The most profiled ocular …

Autoantibodies (AAbs) against glycolytic enzymes: aldolase, α-enolase, glyceraldehyde-3-
phosphate dehydrogenase, and pyruvate kinase are prevalent in sera of patients with …

Purpose To elicit and evaluate opinions in the diagnosis and management of
nonparaneoplastic autoimmune retinopathy (npAIR) among members of the American …

Purpose To examine the efficacy of rituximab as a monotherapy or in combination therapy
for the treatment of patients with non-paraneoplastic autoimmune retinopathy. Methods …

Purpose To report a case of unilateral cancer-associated retinopathy (CAR) with clinical,
serological and electroretinogram (ERG) normalization after aggressive cancer treatment …

Purpose To evaluate clinical and ancillary testing, including adaptive optics, outcomes in
autoimmune retinopathy (AIR) patients treated with rituximab. Design Retrospective …